tiprankstipranks
Viridian Therapeutics (GB:0K1R)
LSE:0K1R
UK Market

Viridian Therapeutics (0K1R) Income Statement

Compare
1 Followers

Viridian Therapeutics Income Statement

Last quarter (Q3 2024), Viridian Therapeutics's total revenue was $86.00K, an increase of 19.44% from the same quarter last year. In Q3, Viridian Therapeutics's net income was $-76.69M. See Viridian Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 314.00K$ 1.77M$ 2.96M$ 1.05M$ 4.46M
Gross Profit
$ -1.01M$ 1.02M$ 2.34M$ -27.25M$ -28.33M
Operating Expenses
$ 254.76M$ 136.08M$ 82.69M$ 41.57M$ 46.44M
Depreciation and Amortization
$ 522.00K$ 755.00K$ 620.00K$ 539.00K$ 288.00K
EBITDA
$ -234.56M$ -128.63M$ -78.79M$ -109.67M$ -40.75M
Operating Income
$ -254.45M$ -134.30M$ -79.73M$ -110.38M$ -41.98M
Other Income/Expenses
$ 16.72M$ 4.43M$ 315.00K$ -335.00K$ 106.00K
Pretax Income
$ -237.73M$ -129.87M$ -79.41M$ -110.72M$ -41.87M
Net Income
$ -237.73M$ -125.44M$ -79.42M$ -110.98M$ -42.42M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.31$ -3.91$ -6.66$ -31.20$ -20.31
Diluted EPS
$ -5.31$ -3.91$ -6.66$ -31.20$ -20.31
Weighted Average Shares Outstanding
44.76M 32.09M 11.92M 3.56M 2.09M
Weighted Average Shares Outstanding (Diluted)
44.76M 32.09M 11.92M 3.56M 2.09M
Currency in USD

Viridian Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis